Terms: = Bone cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
24 results:
1. Precise CRISPR-Cas9 gene repair in autologous memory T cells to treat familial hemophagocytic lymphohistiocytosis.
Li X; Wirtz T; Weber T; Lebedin M; Lowenstein ED; Sommermann T; Zach A; Yasuda T; de la Rosa K; Chu VT; Schulte JH; Müller I; Kocks C; Rajewsky K
Sci Immunol; 2024 Feb; 9(92):eadi0042. PubMed ID: 38306418
[TBL] [Abstract] [Full Text] [Related]
2. Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.
Huuhtanen J; Adnan-Awad S; Theodoropoulos J; Forstén S; Warfvinge R; Dufva O; Bouhlal J; Dhapola P; Duàn H; Laajala E; Kasanen T; Klievink J; Ilander M; Jaatinen T; Olsson-Strömberg U; Hjorth-Hansen H; Burchert A; Karlsson G; Kreutzman A; Lähdesmäki H; Mustjoki S
Leukemia; 2024 Jan; 38(1):109-125. PubMed ID: 37919606
[TBL] [Abstract] [Full Text] [Related]
3. MiR-128-3p as blood based liquid biopsy biomarker in childhood acute lymphoblastic leukemia.
Rzepiel A; Horváth A; Kutszegi N; Gézsi A; Sági JC; Almási L; Egyed B; Lőrincz P; Visnovitz T; Kovács GT; Szalai C; Semsei ÁF; Erdélyi DJ
Mol Cell Probes; 2023 Feb; 67():101893. PubMed ID: 36640912
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study.
Duffaud F; Italiano A; Bompas E; Rios M; Penel N; Mir O; Piperno-Neumann S; Chevreau C; Delcambre C; Bertucci F; Boudou-Rouquette P; Cancel M; Perrin C; Saada-Bouzid E; Monard L; Schiffler C; Chaigneau L; Hervieu A; Collard O; Bouvier C; Vidal V; Chabaud S; Blay JY;
Eur J Cancer; 2021 Jun; 150():108-118. PubMed ID: 33895682
[TBL] [Abstract] [Full Text] [Related]
5. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
[TBL] [Abstract] [Full Text] [Related]
6. EBV Negative Lymphoma and Autoimmune Lymphoproliferative Syndrome Like Phenotype Extend the Clinical Spectrum of Primary Immunodeficiency Caused by STK4 Deficiency.
Schipp C; Schlütermann D; Hönscheid A; Nabhani S; Höll J; Oommen PT; Ginzel S; Fleckenstein B; Stork B; Borkhardt A; Stepensky P; Fischer U
Front Immunol; 2018; 9():2400. PubMed ID: 30386345
[TBL] [Abstract] [Full Text] [Related]
7. A novel chalcone derivative, LQFM064, induces breast cancer cells death via p53, p21, KIT and PDGFRA.
Cabral BLS; da Silva ACG; de Ávila RI; Cortez AP; Luzin RM; Lião LM; de Souza Gil E; Sanz G; Vaz BG; Sabino JR; Menegatti R; Valadares MC
Eur J Pharm Sci; 2017 Sep; 107():1-15. PubMed ID: 28627468
[TBL] [Abstract] [Full Text] [Related]
8. The surgical management and treatment of metastatic lesions in the proximal femur: A mini review.
Feng H; Wang J; Xu J; Chen W; Zhang Y
Medicine (Baltimore); 2016 Jul; 95(28):e3892. PubMed ID: 27428183
[TBL] [Abstract] [Full Text] [Related]
9. CT-Guided Percutaneous Femoroplasty (pfp) for the treatment of Proximal Femoral Metastases.
Feng H; Wang J; Guo P; Xu J; Chen W; Zhang Y
Pain Physician; 2016 Jul; 19(5):E767-73. PubMed ID: 27389120
[TBL] [Abstract] [Full Text] [Related]
10. Activity of Artemisia annua and artemisinin derivatives, in prostate carcinoma.
Michaelsen FW; Saeed ME; Schwarzkopf J; Efferth T
Phytomedicine; 2015 Dec; 22(14):1223-31. PubMed ID: 26655404
[TBL] [Abstract] [Full Text] [Related]
11. Percutaneous femoroplasty for the treatment of proximal femoral metastases.
Feng H; Feng J; Li Z; Feng Q; Zhang Q; Qin D; Chen W; Li Z; Zhang Y
Eur J Surg Oncol; 2014 Apr; 40(4):402-5. PubMed ID: 24411706
[TBL] [Abstract] [Full Text] [Related]
12. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
[TBL] [Abstract] [Full Text] [Related]
13. Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis.
Strout MP; Seropian S; Berliner N
Nat Rev Clin Oncol; 2010 Jul; 7(7):415-20. PubMed ID: 20404855
[TBL] [Abstract] [Full Text] [Related]
14. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
Sleijfer S; Ray-Coquard I; Papai Z; Le Cesne A; Scurr M; Schöffski P; Collin F; Pandite L; Marreaud S; De Brauwer A; van Glabbeke M; Verweij J; Blay JY
J Clin Oncol; 2009 Jul; 27(19):3126-32. PubMed ID: 19451427
[TBL] [Abstract] [Full Text] [Related]
15. Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: a phase II study from the European Organisation for Research and treatment of cancer Soft Tissue and bone Sarcoma Group.
Leahy M; Ray-Coquard I; Verweij J; Le Cesne A; Duffaud F; Hogendoorn PC; Fowst C; de Balincourt C; di Paola ED; van Glabbeke M; Judson I; Blay JY;
Eur J Cancer; 2007 Jan; 43(2):308-15. PubMed ID: 17095209
[TBL] [Abstract] [Full Text] [Related]
16. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
[TBL] [Abstract] [Full Text] [Related]
17. The role of surgery in stage IV neuroblastoma.
Castel V; Tovar JA; Costa E; Cuadros J; Ruiz A; Rollan V; Ruiz-Jimenez JI; Perez-Hernández R; Cañete A
J Pediatr Surg; 2002 Nov; 37(11):1574-8. PubMed ID: 12407542
[TBL] [Abstract] [Full Text] [Related]
18. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Vogel VG
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
[TBL] [Abstract] [Full Text] [Related]
19. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
Dunn BK; Ford LG
Breast J; 2001; 7(3):144-57. PubMed ID: 11469927
[TBL] [Abstract] [Full Text] [Related]
20. Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3.
Hejna JA; Timmers CD; Reifsteck C; Bruun DA; Lucas LW; Jakobs PM; Toth-Fejel S; Unsworth N; Clemens SL; Garcia DK; Naylor SL; Thayer MJ; Olson SB; Grompe M; Moses RE
Am J Hum Genet; 2000 May; 66(5):1540-51. PubMed ID: 10762542
[TBL] [Abstract] [Full Text] [Related]
[Next]